BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7664268)

  • 61. Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma.
    Moskaluk CA; Rumpel CA
    Cancer; 1998 Jul; 83(2):232-9. PubMed ID: 9669804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer.
    Chughtai SA; Crundwell MC; Cruickshank NR; Affie E; Armstrong S; Knowles MA; Takle LA; Kuo M; Khan N; Phillips SM; Neoptolemos JP; Morton DG
    Oncogene; 1999 Jan; 18(3):657-65. PubMed ID: 9989816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
    Zhang Z; Gerhard DS; Nguyen L; Li J; Traugott A; Huettner PC; Rader JS
    Genes Chromosomes Cancer; 2005 May; 43(1):95-103. PubMed ID: 15672406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.
    Fujiwara Y; Emi M; Ohata H; Kato Y; Nakajima T; Mori T; Nakamura Y
    Cancer Res; 1993 Mar; 53(5):1172-4. PubMed ID: 8439963
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Deletion map of human chromosome 11 in lung cancers].
    Iizuka M; Sekiya T
    Nihon Rinsho; 1996 Feb; 54(2):472-7. PubMed ID: 8838099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
    Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma.
    Herbst RA; Gutzmer R; Matiaske F; Mommert S; Casper U; Kapp A; Weiss J
    Int J Cancer; 1999 Jan; 80(2):205-9. PubMed ID: 9935201
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma.
    Mugica-Van Herckenrode C; Rodriguez JA; Iriarte-Campo V; Carracedo A; Barros F
    Diagn Mol Pathol; 1999 Jun; 8(2):92-6. PubMed ID: 10475383
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.
    Bepler G; Garcia-Blanco MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5513-7. PubMed ID: 8202519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Allelic losses in human chromosome 11 in lung cancers.
    Iizuka M; Sugiyama Y; Shiraishi M; Jones C; Sekiya T
    Genes Chromosomes Cancer; 1995 May; 13(1):40-6. PubMed ID: 7541642
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B.
    O'Briant KC; Bepler G
    Genes Chromosomes Cancer; 1997 Feb; 18(2):111-4. PubMed ID: 9115960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis.
    Keldysh PL; Dragani TA; Fleischman EW; Konstantinova LN; Perevoschikov AG; Pierotti MA; Della Porta G; Kopnin BP
    Genes Chromosomes Cancer; 1993 Jan; 6(1):45-50. PubMed ID: 7680221
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Loss of heterozygosity on chromosome 11 q in breast cancer.
    Tomlinson IP; Strickland JE; Lee AS; Bromley L; Evans MF; Morton J; McGee JO
    J Clin Pathol; 1995 May; 48(5):424-8. PubMed ID: 7629288
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma.
    Bello MJ; Moreno S; Rey JA
    Cancer Genet Cytogenet; 1989 Mar; 38(1):133-5. PubMed ID: 2713811
    [No Abstract]   [Full Text] [Related]  

  • 75. Identification of VWA5A as a novel biomarker for inhibiting metastasis in breast cancer by machine-learning based protein prioritization.
    Koh J; Jeong D; Park SY; Han D; Kim DS; Kim HY; Kim H; Yang S; Kim S; Ryu HS
    Sci Rep; 2024 Jan; 14(1):2459. PubMed ID: 38291227
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A review on role of ATM gene in hereditary transfer of colorectal cancer.
    Sriramulu S; Ramachandran M; Subramanian S; Kannan R; Gopinath M; Sollano J; Bissi L; Banerjee A; Marotta F; Pathak S
    Acta Biomed; 2019 Jan; 89(4):463-469. PubMed ID: 30657113
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-β Pathway.
    Fang LL; Sun BF; Huang LR; Yuan HB; Zhang S; Chen J; Yu ZJ; Luo H
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257105
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The distribution and functional relevance analysis of runs of homozygosity (ROHs) in Chinese Han female population.
    Lu YH; Wang BH; Xia W; Mo XB; Wu LF; Zhu XW; He P; Xie FF; Lu X; Deng FY; Lei SF
    Mol Genet Genomics; 2018 Feb; 293(1):197-206. PubMed ID: 28980070
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications.
    Zenata O; Vrzal R
    Oncotarget; 2017 May; 8(21):35390-35402. PubMed ID: 28427151
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
    Xu L; Li M; Wang M; Yan D; Feng G; An G
    BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.